Click here to read the notification from STADA advising of the introduction of a new presentation.

Note:- A majority of prescribers will prescribe the new 5 ml ampoules so please check

New presentation:-

MOVAPO Injection 50 mg / 5 ml 5 ampoules                       Pharmacode 2581159 Schedule price $121.84

Current presentation:-

MOVAPO Injection 20 mg / 2 ml 5 ampoules                        Pharmacode 2498723 Schedule price $119.00 (reducing to $59.50 effective 1 January 2020)

Please note that ProPharma / PWR reduced the price effective from 12 December 2019.

New presentation will be available from 12 January 2020, and Fully Funded from 1 February 2020.

As per the information provided by STADA they anticipate a significant drop in demand for MOVAPO 20 mg / 2 ml.  That raises a potential issue with respect to stock holding and supply which we will manage accordingly.

During the transition ProPharma /PWR will reduce stock holding by centralising stock holding of the 2 ml presentation to potentially two branches. While this will mean a slight delay in your order receipt it will prevent excess stock being held and potentially written off.

We have the new presentation available to purchase now.

We ask that you support us through this transition. It is not our desire to delay processing and delivery of stock, but in this situation we need to manage stock extremely well to avoid creating potential losses for pharmacy and / or wholesaler.

Should you wish to discuss this matter please contact your local Branch Manager or your Key Account Manager.

Thanking you in anticipation of your assistance.

About The Author